NOVAREX Co.,Ltd. (KOSDAQ:194700)

South Korea · Delayed Price · Currency is KRW

12,870

-600 (-4.45%)

At close: Jul 20, 2026

-40.00% (1Y)

Market Cap	221.39B -43.2%
Revenue (ttm)	404.26B +35.8%
Net Income	35.42B +53.9%
EPS	2,000.10 +53.9%
Shares Out	17.20M
PE Ratio	6.43
Forward PE	n/a
Dividend	400.00 (2.97%)
Ex-Dividend Date	Dec 29, 2025

Volume	58,749
Open	13,370
Previous Close	13,470
Day's Range	12,820 - 13,450
52-Week Range	10,990 - 22,050
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor... [Read more]

Industry Pharmaceutical Preparations

Founded 1995

Employees 464

Stock Exchange KOSDAQ

Ticker Symbol 194700

Full Company Profile

Financial Performance

In 2025, NOVAREX's revenue was 404.26 billion, an increase of 35.78% compared to the previous year's 297.73 billion. Earnings were 35.42 billion, an increase of 53.87%.

Financial Statements